Smart Devices-based Longitudinal Assessment of Patterns of Insomnia

Status

Enrolling by invitation

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07430878

Acronym

SLEEPI

Enrollment

17000

Registered

2026-02-24

Start date

2025-02-18

Completion date

2027-05-17

Last updated

2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Brief summary

The objective of the study is to develop an algorithm to detect insomnia and classify its severity, based on data collected during the use of Withings products and from questionnaires sent to users

Interventions

DEVICEUse of the Withings sleep-related devices

The participants are asking to use their Withings sleep-related device(s) as much as possible

OTHERQuestionnaires

The participant are asking to answer several questionnaires regarding their quality of sleep via Withings mobile application

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* is an adult(18 years old or more). * is affiliated or eligible to a social security system. * has expressed their consent to take part in the study. * owns any of the following Withings monitoring devices: ScanWatch, ScanWatch 2 or Sleep Analyzer. * has Withings mobile application with version greater or equal to 5.12.

Exclusion criteria

* Minors under 18 years old. * Subjects having refused to give their consent. * Vulnerable subjects according to the country regulation in force: * Individuals deprived of liberty by a court, medical or administrative order, * Individuals legally protected or unable to express their consent to take part in the study, * Individuals unaffiliated to or not beneficiary of a social security system, * Individuals who fit in multiple categories above, * Individuals linguistically or mentally unable to express their consent.

Design outcomes

Primary

Measure	Time frame
insomnia presence/absence using a Questionnaire	From enrollment and for 26 weeks
Severity of Insomnia using a Questionnaire	: From enrollment and for 26 weeks

Secondary

Measure	Time frame
The rate and duration of use the Withings device and the questionnaire answered	From enrollment and for 26 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026